Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells

Cardiovasc Res. 2005 Sep 1;67(4):714-22. doi: 10.1016/j.cardiores.2005.04.017.

Abstract

Objective: Thickened atherosclerotic plaques are prone to be hypoxic because of poor perfusion. In this study, we tested (a) whether reactive oxygen species (ROS) and c-Src play roles in hypoxic induction of HIF-1alpha protein and PAI-1 gene expression in the rabbit aortic smooth muscle cell line C2/2 cells and primary cultures of rat aortic smooth muscle cells, and (b) how mitochondria act on the hypoxia-induced signaling mechanism.

Methods and results: Hypoxic exposure of C2/2 cells increased H2O2 generation, c-Src phosphorylation, HIF-1alpha protein expression, and PAI-1 gene expression. Catalase, a scavenger of H2O2, inhibited the hypoxia-induced ROS generation and PAI-1 gene expression. Src kinase inhibitors PP1 and PP2 inhibited hypoxia-induced HIF-1alpha protein and PAI-1 gene expression. Ablation of mitochondrial respiration by rotenone abolished hypoxia-induced ROS generation, c-Src phosphorylation, HIF-1alpha protein expression, and PAI-1 gene expression.

Conclusion: Induction of HIF-1alpha protein and PAI-1 gene expression in response to hypoxia was regulated by ROS production and c-Src activation in vascular smooth muscle cells. Mitochondria linked the hypoxic signal to c-Src, which in turn led to HIF-1alpha protein and PAI-1 gene expression. These results provide evidence that hypoxia induces the ROS-mediated and c-Src-dependent signaling cascades which are closely associated with angiogenesis and thrombosis in atherosclerotic vasculature.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstadienes / pharmacology
  • Animals
  • Blotting, Northern
  • Catalase / pharmacology
  • Cell Hypoxia
  • Cell Line
  • Flavonoids / pharmacology
  • Hydrogen Peroxide / metabolism*
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Imidazoles / pharmacology
  • Immunoblotting
  • Microscopy, Fluorescence
  • Mitochondria / metabolism*
  • Muscle, Smooth, Vascular*
  • Myocytes, Smooth Muscle / metabolism*
  • Naphthalenes / pharmacology
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Plasminogen Activator Inhibitor 1 / genetics
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins pp60(c-src) / metabolism*
  • Pyrazoles / pharmacology
  • Pyridines / pharmacology
  • Pyrimidines / pharmacology
  • RNA, Messenger / analysis
  • Rabbits
  • Rotenone / pharmacology
  • Wortmannin

Substances

  • 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine
  • AG 1879
  • Androstadienes
  • Flavonoids
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Imidazoles
  • Naphthalenes
  • Phosphoinositide-3 Kinase Inhibitors
  • Plasminogen Activator Inhibitor 1
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyridines
  • Pyrimidines
  • RNA, Messenger
  • calphostin complex
  • Rotenone
  • Hydrogen Peroxide
  • Catalase
  • Proto-Oncogene Proteins pp60(c-src)
  • SB 203580
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Wortmannin